Warfarin sodium: steady-state plasma levels and patient age. 1978

K Hotraphinyo, and E J Triggs, and B Maybloom, and A Maclaine-Cross

1. Steady-state plasma levels of warfarin were measured in thirty-nine ambulatory patients attending a haematology clinic. 2. Plasma concentrations, plasma clearance, and prothrombin ratio showed no significant differences when patients below 65 years of age were compared with those above 65 years. The mean daily maintenance dose of warfarin required was marginally greater for the younger patients but the difference was not statistically significant (P = 0.10). 3. A significant relationship was found between the daily maintenance dose of warfarin required by all patients and their mean steady-state plasma level (r = 0.5667, P less than 0.001). 4. For one elderly hospitalized patient it was apparent that there was a marked depression of the vitamin K-dependent clotting factor synthesis by warfarin which was associated with a hypoprothrombinaemic response.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

K Hotraphinyo, and E J Triggs, and B Maybloom, and A Maclaine-Cross
November 1995, Clinical pharmacology and therapeutics,
K Hotraphinyo, and E J Triggs, and B Maybloom, and A Maclaine-Cross
November 1989, Therapeutic drug monitoring,
K Hotraphinyo, and E J Triggs, and B Maybloom, and A Maclaine-Cross
December 1981, British journal of clinical pharmacology,
K Hotraphinyo, and E J Triggs, and B Maybloom, and A Maclaine-Cross
January 1987, Therapeutic drug monitoring,
K Hotraphinyo, and E J Triggs, and B Maybloom, and A Maclaine-Cross
December 1980, Clinical pharmacology and therapeutics,
K Hotraphinyo, and E J Triggs, and B Maybloom, and A Maclaine-Cross
December 1982, British journal of clinical pharmacology,
K Hotraphinyo, and E J Triggs, and B Maybloom, and A Maclaine-Cross
February 1976, Clinical pharmacology and therapeutics,
K Hotraphinyo, and E J Triggs, and B Maybloom, and A Maclaine-Cross
September 1979, British journal of clinical pharmacology,
K Hotraphinyo, and E J Triggs, and B Maybloom, and A Maclaine-Cross
April 1982, The American journal of psychiatry,
K Hotraphinyo, and E J Triggs, and B Maybloom, and A Maclaine-Cross
December 1991, Clinical pharmacy,
Copied contents to your clipboard!